Related Read: 14 Peptides Are About to Become Legal Again What This Means for Your Health What the science says about peptide stacking as a category 1) Combination trials are the exception, not the rule For many popular peptides, we have: mechanistic arguments small studies (sometimes in narrow contexts) preclinical work We rarely have: well-powered, long-term human trials on the combination hard outcomes (function, cardiometabolic endpoints, durability, safety) 2) Stacking amplifies the two biggest risks in this space Quality risk (variable purity, contamination, labeling issues) Physiology risk (more pathways affected, more unintended effects) 3) The GH/IGF-1 axis is where stacking gets most clinically delicate CJC-1295 has human data showing it raises GH/IGF-1

I'll occasionally take it every once in a while, but in general, I just stopped taking it because whatever the positive effects might've been, if I had taken it more consistently, the effects in depleting rapid eye movement sleep were just something I didn't want and don't want
Lastly the only means of effect are measured via subjective data
Body areas affected by acanthosis nigricans include the following: Back of neck (nape) Underarms Groin folds Under breasts Elbows and knees Knuckles and toes Face Navel Palms and soles How Do Doctors Diagnose Acanthosis Nigricans